WHO gives ‘emergency validation’ to Pfizer-BioNTech corona vaccine, calls for equitable global access

The WHO, together with the GAVI Vaccine Alliance and the Coalition for Epidemic Preparedness Innovations (CEPI), are spearheading a global effort called COVAX to distribute vaccines to low- and middle-income countries.

world health organisation emergency use authorisation to pfizer vaccine

Pfizer share price zooms over 19% to new 52-week high on COVID-19 vaccine news; rallies 63% since March

Pfizer also indicated that the company is on track later this month to file an emergency use application with US regulators.

Pfizer vaccine, Pfizer covid-19 vaccine, pfizer share price

Pfizer signs definitive merger agreement with Anacor Pharmaceuticals

To acquire Anacor Pharmaceuticals for $5.2 billion Pfizer and Anacor Pharmaceuticals have entered into a definitive merger agreement under which Pfizer will acquire Anacor for $99.25 per Anacor share, in cash, for a total tra

Piramal Enterprises acquires four brands from Pfizer for Rs 110 crore

The agreement also includes the trademark rights for Ferradol and Waterbury’s Compound in Bangladesh and Sri Lanka Piramal Enterprises’ Consumer Products Division has entered into an agreement to acquire four brands from

Pfizer says it’s blocking use of drugs for lethal injections

Pharmaceutical company Pfizer said Friday it was blocking use of its drugs in lethal injections, which means all federally-approved drugmakers whose medications could be used for executions have now put them off limits.


Pfizer Q4 net profit spikes 57 pc to Rs 67 cr

Drug firm Pfizer on Friday reported a 56.9 per cent rise in its standalone net profit at Rs 66.9 crore for the March quarter.

Pfizer Q4 results

Delhi HC questions govt over urgency to ban over 300 FDC drugs

Additional Solicitor General was responding to the contentions of pharma companies like Pfizer, Glenmark, Procter and Gamble and Cipla

Pfizer calls off $160-billion merger with Allergan

The decision to call off the merger came after the US Treasury Department announced new rules to discourage mergers between US and foreign businesses designed to sharply lower the US company’s tax bill US pharmaceutical

Is pharma companies still a good bet post drugs ban?

Shares of pharmaceutical companies hogged the limelight this week after the Ministry of Health & Family Welfare banned sale of over 300 fixed-dose combinations (FDC) in India with immediate effect.


Delhi High Court interim stay of notification stopping sale of Corex syrup

Justice Rajiv Sahai Endlaw granted the interim relief to the company saying it has been selling the cough syrup for the last 25 years

Court stays ban on Pfizer’s Corex cough syrup

In a relief to pharma major Pfizer and giving hopes for several others, the Delhi High Court on Monday stayed a government notification that banned manufacture...

Pfizer Q4 results

Health Ministry bans 344 fixed dose combination drugs

Health Ministry has banned about 344 fixed dose combination drugs, including cough syrups compositions, saying they involve "risk" to humans and safer alternatives were available.


Pfizer stops sale of Corex after government ban

Pfizer said Corex maintains a ‘well established efficacy and safety profile in India’ and the ‘company is exploring all available options at its disposal’ Pfizer has discontinued manufacture and sale o

Pfizer shares tanks over 8% after it stops selling Corex cough syrup

Pfizer share price skid over 7 per cent intraday on Monday after the company informed stock exchanges that it has discontinued the manufacture and sale of its drug “Corex” with immediate effect.


Pfizer launches Gelusil liquid in sachet format

The product has been rolled out simultaneously in metros, smaller towns and rural areas Pfizer’s GEP (Global Established Products) division in India has kaunched Gelusil liquid in a ready-to-drink, on-the-go sachet format.

EMA accepts Sandoz application for biosim etanercept

The EMA's acceptance follows recent US FDA regulatory submission acceptance

Pfizer, IIT Delhi launch ‘Innovation & IP Program’

The programme will help to create healthcare innovations in India Pfizer with IIT Delhi have announced the launch of ‘The Pfizer IIT-Delhi Innovation and IP Program’, an incubation accelerator initiative co-created by Pfi

Pfizer shares zoom nearly 9% on Allergen deal

Shares of Pfizer rose sharply by nearly 9 per cent intraday on Tuesday after its parent Pfizer Inc's announcement to buy Botox manufacturer Allergan in a record $160 billion deal, a biggest buyout in the global healthcare sec

Pfizer Pharmaceutical

Pfizer to buy Allergan in $160 bn deal to become world’s largest drugmaker

Pfizer Inc, the maker of Viagra and Lipitor, has struck a deal to buy Botox-maker Allergan Plc in a transaction valued at about $160 billion.

Pfizer to buy Allergan in $160 billion deal

Shares of Allergan fell 3.4 per cent and Pfizer closed down 2.6 per cent as investors learned the merger, under discussion since late October, would bring lower cost savings than they had hoped.

Pfizer Allergan

India battles big pharma over cough syrup abuse, reducing supplies

Regulators want to make it easier for law enforcement agencies to track cough syrup abuse in the country and bottles smuggled to neighbouring Bangladesh, where it was banned in the 1980s but is still sought by addicts.

cough syrup codeine

Pfizer India MD Aijaz Tobaccowalla resigns

The day-to-day operations at Pfizer will be managed by its Executive Director, Business Unit and Distribution Head S Sridhar till Aijaz Tobaccowalla's successor is appointed.

Pfizer to sell its Thane plant to Vidhi Research and Development

All current workmen at the Thane plant shall be transferred to the buyer so as to facilitate manufacturing operations Pfizer has entered into a business transfer agreement to sell its Thane plant as a going concern to Vidhi R

Pfizer to sell Thane plant to Vidhi Research for Rs 178 crore

In July, Pfizer announced that it will close its over 50-year old Thane plant from September 16, 2015, which was lying idle since 2013.

India rejects Pfizer’s patent application for arthritis drug

Quoting a Supreme Court judgement, the order said that the applicant would have to establish the therapeutic enhanced efficacy of the claimed compound over the base compound India’s patent office has again rejected US drug

Pfizer’s patent application for arthritis drug rejected

The patent office in Mumbai was directed by Intellectual Property Appellate Board (IPAB) to re-consider Pfizer's patent application.

Income Tax Calculator, Budget 2019, How to Calculate Income Tax


Stock Market

Most Read


Top News


Related Articles